Filter posts

Voting Now Open for the Buzz of BIO at the 2015 BIO CEO & Investor Conference

The Buzz of BIO contest at the 2015 BIO CEO & Investor Conference recognizes highly innovative …

2015 BIO CEO & Investor Conference™ to Feature Dynamic List of Company Presentations

Past and future attendees of the annual BIO CEO & Investor Conference have high expectations …

Looking Ahead to the 2014 BIO Investor Forum, Biotech IPO Hopefuls Continue to Seek Funding

As mentioned in Fierce Biotech, a new crop of biotech IPO hopefuls have recently thrown their …

Rare Disease Day 2014: Joining Together for Better Care

There are more than 6,000 different rare diseases affecting over 60 million people across Europe …

Post-Con BIO CEO Company Snapshot: Immunovaccine

A few weeks ago, the BIO CEO & Investor Conference concluded in New York City. …

U.S. Rep. Charlie Dent Discusses PDUFA and NIH Funding at #BIOCEO14

During the 16th Annual BIO CEO & Investor Conference, U.S. Representative Charlie Dent of Pennsylvania, …

Immuno Oncology - A 30-year Overnight Success Story

“It was the Rodney Dangerfield space – couldn’t get no respect” One would never guess …

The Economist – Biotechnology: Fever Rising

After speaking with several attendees and speakers at last week’s BIO CEO & Investor Conference, the …

Business Roundtable: The Reimbursement Landscape under ACA

As the Affordable Care Act is implemented, reimbursement for life-saving and life-enhancing drugs is one …

#BIOCEO14: An Optimistic Outlook for 2014

The 16th Annual BIO CEO & Investor Conference​ concluded with a lively Closing Plenary Session examining …